Hester Biosciences Ltd.

Hester Biosciences Ltd.

HESTERBIO

Small CapPharmaceuticals
Hester Biosciences Ltd.

Hester Biosciences Ltd.

HESTERBIO

Small CapPharmaceuticals

Hester Biosciences Ltd. Share Price

2,069.90 -97.30 (-4.49%)

Share Price Today – Hester Biosciences Ltd.

As of October 9, 2026, Hester Biosciences Ltd. share price is ₹2,069.90. The stock opened at ₹2,167.10 and closed at ₹2,167.20 in the previous session. During the trading session, the share price moved between ₹2,051.00 and ₹2,174.90. Over the last 52 weeks, the stock has recorded a low of ₹1,239.30 and a high of ₹2,683.60. In terms of performance, the stock has delivered 46.5% returns over the past six months and 17.7% returns over the last year.

About the company

Hester Biosciences is principally engaged in manufacturing of veterinary vaccines and trading of veterinary health products. The Company has two principal operating and reporting segments viz. Poultry healthcare and Animal healthcare.
Crisp AnalysisAnalysis

Powerful momentum with quality support

Today's Low
2,051.00
Today's High
2,174.90
52W Low
1,239.30
52W High
2,683.60

Fundamentals

Market Cap

₹1,778Cr

EPS

₹67.56

Book Value/Share

₹534.78

P/E Ratio (TTM)

13.53

Industry P/E (TTM)

47.30

P/B Ratio

5.11

Long Term D/E

0.54

ROE

16.49%

Dividend Yield (TTM)

0.50%

Sector P/E Ratio (TTM)

40.63

Sector P/B Ratio

5.53

Shareholding Pattern

Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.

Top mutual funds holding Hester Biosciences Ltd.

FAQs on Hester Biosciences Ltd.

The share price of Hester Biosciences Ltd. is ₹2,069.90 on NSE as of 9/10/2026, 1:44:31 am. Share prices may change frequently due to market movements.

The market capitalisation of Hester Biosciences Ltd. is ₹1,778Cr as of 9/10/2026, 1:44:31 am

The current Price to Earnings (P/E) ratio of Hester Biosciences Ltd. is 13.54 as of 9/10/2026, 1:44:31 am

The Price to Book (P/B) ratio of Hester Biosciences Ltd. stands at 5.12 as of 9/10/2026, 1:44:31 am

Hester Biosciences Ltd. reported an ROE of 16.50% for the last reported financial year on a consolidated account basis.

As of 9/10/2026, 1:44:31 am, Hester Biosciences Ltd.’s shareholding pattern is: promoters hold 53.70%, FIIs hold 0.30%, DIIs hold 0.00%, and public shareholders hold 46.00%.

The 52-week high of Hester Biosciences Ltd. is ₹2,683.60 and the 52-week low is ₹1,239.30 as of 9/10/2026, 1:44:31 am.

The earnings per share (EPS) of Hester Biosciences Ltd. is -- for the quarter ended Sep 2026.

The stock symbol of Hester Biosciences Ltd. is HESTERBIO.

You can buy Hester Biosciences Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.

The fair value of Hester Biosciences Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.

Overview

Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.

Strong Outperformer

Good Quality

Low Price Fluctuation

Disclosure and Disclaimer

Earnings Per Share

Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.

Income Statement

Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.

Particulars (in Cr)Jun 2026Q/Q Change
Operating Revenue77.24-22.84%
Other Income1.64-154.13%
Total Income78.89-18.74%
Total Expenditure54.47-17.19%
EBIDT109.77+220.59%
Depreciation7.04+19.12%
Interest3.08-39.61%
Tax4.95-42.04%
Net Profit96.98+506.88%

Balance Sheet

A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.

Particulars (in Cr)Mar 2026
Total Current Assets208.56
Total Non-Current Assets469.38
Fixed assets420.78
Total Assets677.94
Total Current liabilities152.48
Total Non Current Liabilities157.67
Total Equity Plus Liabilities677.94
Total Shareholder Funds360.24
Total Debt to Equity52.00%

Cash Flow

Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.

Particulars (in Cr)Mar 2026
Cash from Operating Activity64.14
Cash from Financing Activities-48.79
Cash from Investing Activities-2.87
Net Cash Flow12.48

Time Period: Daily

SMA/EMA (Moving Average) Analysis

Bullish Moving Averages3

Bearish Moving Averages13

5 Day

2,149.90

10 Day

2,168.80

20 Day

2,203.00

30 Day

2,234.50

50 Day

2,319.80

100 Day

2,222.30

150 Day

1,982.30

200 Day

1,871.30

Indicators

RSI (14)

44.28

MACD (12, 26)

-44.03

MACD Signal Line (9)

-44.73

MFI (14)

56.33

ATR (14)

87.46

ADX (14)

13.73

ROC (21)

-9.90

ROC (125)

51.88

Pivot Analysis

Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.

TypeR1R2R3PPS1S2S3
Classic0.000.000.000.000.000.000.00

Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.

Volume Analysis

Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.

Share Price Today – Hester Biosciences Ltd.

As of October 9, 2026, Hester Biosciences Ltd. share price is ₹2,069.90. The stock opened at ₹2,167.10 and closed at ₹2,167.20 in the previous session. During the trading session, the share price moved between ₹2,051.00 and ₹2,174.90. Over the last 52 weeks, the stock has recorded a low of ₹1,239.30 and a high of ₹2,683.60. In terms of performance, the stock has delivered 46.5% returns over the past six months and 17.7% returns over the last year.

About the company

Hester Biosciences is principally engaged in manufacturing of veterinary vaccines and trading of veterinary health products. The Company has two principal operating and reporting segments viz. Poultry healthcare and Animal healthcare.
Crisp AnalysisAnalysis

Powerful momentum with quality support

Today's Low
2,051.00
Today's High
2,174.90
52W Low
1,239.30
52W High
2,683.60

Fundamentals

Market Cap

₹1,778Cr

EPS

₹67.56

Book Value/Share

₹534.78

P/E Ratio (TTM)

13.53

Industry P/E (TTM)

47.30

P/B Ratio

5.11

Long Term D/E

0.54

ROE

16.49%

Dividend Yield (TTM)

0.50%

Sector P/E Ratio (TTM)

40.63

Sector P/B Ratio

5.53

Shareholding Pattern

Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.

Top mutual funds holding Hester Biosciences Ltd.

FAQs on Hester Biosciences Ltd.

The share price of Hester Biosciences Ltd. is ₹2,069.90 on NSE as of 9/10/2026, 1:44:31 am. Share prices may change frequently due to market movements.

The market capitalisation of Hester Biosciences Ltd. is ₹1,778Cr as of 9/10/2026, 1:44:31 am

The current Price to Earnings (P/E) ratio of Hester Biosciences Ltd. is 13.54 as of 9/10/2026, 1:44:31 am

The Price to Book (P/B) ratio of Hester Biosciences Ltd. stands at 5.12 as of 9/10/2026, 1:44:31 am

Hester Biosciences Ltd. reported an ROE of 16.50% for the last reported financial year on a consolidated account basis.

As of 9/10/2026, 1:44:31 am, Hester Biosciences Ltd.’s shareholding pattern is: promoters hold 53.70%, FIIs hold 0.30%, DIIs hold 0.00%, and public shareholders hold 46.00%.

The 52-week high of Hester Biosciences Ltd. is ₹2,683.60 and the 52-week low is ₹1,239.30 as of 9/10/2026, 1:44:31 am.

The earnings per share (EPS) of Hester Biosciences Ltd. is -- for the quarter ended Sep 2026.

The stock symbol of Hester Biosciences Ltd. is HESTERBIO.

You can buy Hester Biosciences Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.

The fair value of Hester Biosciences Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.

Hester Biosciences Ltd.

Hester Biosciences Ltd.

HESTERBIO

Small CapPharmaceuticals

Open Price

2,167.10

Previous Close

2,167.20

Volume

2,614

Average Price

2,088.34

Upper Circuit

2,600.60

Lower Circuit

1,733.80
Today's Low
2,051.00
Today's High
2,174.90
52W Low
1,239.30
52W High
2,683.60

Historical Performance

Momentum 5/5
NA1 Day
NA5 Days
NA1 Month
NA3 Months
NA1 Year
NA5 Years
NA10 Years
Trademarks owned by their respective owners are shown here only for ease of recall of the respective owner by public.